Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Roshanak Semnani"'
Autor:
Sasisekhar Bennuru, Roshanak Semnani, Zhaojing Meng, Jose M C Ribeiro, Timothy D Veenstra, Thomas B Nutman
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 3, Iss 4, p e410 (2009)
Relatively little is known about the filarial proteins that interact with the human host. Although the filarial genome has recently been completed, protein profiles have been limited to only a few recombinants or purified proteins of interest. Here,
Externí odkaz:
https://doaj.org/article/029206dcdf0e4bad824179152ef196cf
Autor:
David A. Sallman, Hany Elmariah, Kendra Sweet, Asmita Mishra, Cheryl A Cox, Marion Chakaith, Roshanak Semnani, Sheeba Shehzad, Asha Anderson, Helen Sabzevari, Amy Lankford, Onyee Chan, Luis SanchezMolina, Chen Wang, Eric Padron, Andrew Kuykendall, Rami S. Komrokji, Jeffrey E. Lancet, Marco L. Davila, Nelli Bejanyan
Publikováno v:
Blood. 140:10313-10315
Autor:
David A. Sallman, Hany Elmariah, Kendra Sweet, Chetasi Talati, Asmita Mishra, Cheryl A Cox, Roshanak Semnani, Rutul R Shah, Helen Sabzevari, Marion Chakiath, Justin Uthuppan, Amy Lankford, Chen Wang, Eric Padron, Andrew T. Kuykendall, Rami S. Komrokji, Jeffrey E. Lancet, Marco L. Davila, Nelli Bejanyan
Publikováno v:
Blood. 138:825-825
Introduction: Therapeutic options for relapsed/refractory (r/r) acute myeloid leukemia (AML) and hypomethylating agent (HMA) failure higher risk myelodysplastic syndrome (MDS) are limited with a median overall survival of < 6 months. Although chimeri